Van Andel Research Institute
Add to Favorites Newsroom RSS Share
Grand Rapids, MI USA

Our News on Newswise

Cryo-EM Reveals Critical Protein-Modifying Complex and Potential Drug Target

Scientists have revealed the atomic-level structure of a molecular complex responsible for modifying proteins, possibly paving the way for the development of new medications for cancer and a host of other diseases.
22-Jan-2018 11:00 AM EST Add to Favorites


Cryo-EM Reveals “Crown-Like” Structure of Protein Responsible for Regulating Blood Flow

A team led by scientists at Van Andel Research Institute has revealed for the first time the atomic-level structure of a promising drug target for conditions such as stroke and traumatic brain injury.
6-Dec-2017 1:15 PM EST Add to Favorites


New Research to Target Air Pollution as a Potential Trigger for Parkinson’s

The Department of Defense has awarded a multi-institutional team of scientists a series of grants totaling $4.37 million to investigate the potential role of airborne pollutants as triggers of Parkinson’s disease via the nose.
9-Nov-2017 2:05 PM EST Add to Favorites


Cryo-EM Reveals Ignition Mechanism for DNA Replication

An international team of scientists, led by structural biologists at Van Andel Research Institute, has shed new light on a critical step in DNA replication, offering fresh insights into a fundamental process of life and driver of many different...
23-Oct-2017 3:05 PM EDT Add to Favorites

Stand Up To Cancer awards $5.5 million to VARI for cancer clinical trials to enhance immunotherapy

Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team scientists have been awarded two grants totaling nearly $5.5 million to pursue clinical trials of epigenetic drugs to enhance tumor response to immunotherapy.
12-Oct-2017 10:00 AM EDT Add to Favorites

Van Andel Research Institute Hosts Unique Symposium on Parkinson’s Disease

Leading Parkinson’s experts and advocates from around the world will gather at Van Andel Research Institute in Grand Rapids, Michigan, this month for Grand Challenges in Parkinson’s Disease, a scientific event highlighting the latest...
25-Sep-2017 2:05 PM EDT Add to Favorites


$2.375 Million Federal Award to Study Epigenetic Control Systems, Inform Drug Discovery

Van Andel Research Institute scientist Scott Rothbart, Ph.D., has been awarded a five-year, $2.375 million Maximizing Investigators’ Research Award (MIRA/R35) from the National Institute of General Medical Sciences (NIGMS) of the National...
20-Sep-2017 12:05 PM EDT Add to Favorites

Effects of a Major Drug Target Regulated Through Molecular “Codes”

The findings, published today in Cell, reveal for the first time components of a G protein–coupled receptor (GPCR) named rhodopsin bound to a signaling molecule called arrestin, both crucial pieces of the body’s intricate cellular communication...
27-Jul-2017 10:05 AM EDT Add to Favorites

see all news

Our Experts on Newswise

Van Andel Research Institute (VARI) is continuing the expansion of its neurodegenerative disease research program, which aims to answer fundamental questions about diseases such as Parkinson’s and Alzheimer’s, with the addition of two...
16-Nov-2015 1:00 PM EST

see all experts

Our YouTube Videos

Chat now!